Skip to content

Repeated transcranial magnetic treatment of cognitive impairment in Alzheimer's disease and its neuroimaging study

Repeated transcranial magnetic treatment of cognitive impairment in Alzheimer's disease and its neuroimaging study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050496
Enrollment
Unknown
Registered
2021-08-28
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's disease

Interventions

Experimental group:parietal stimulation
Control group:sham stimulation

Sponsors

Nanjing Drumtower Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: Meet the diagnostic criteria for Alzheimer's disease.

Exclusion criteria

Exclusion criteria: Suffering from cerebral small vessel disease, Parkinson's disease, Lewy body dementia and other diseases that may cause cognitive impairment in patients.

Design outcomes

Primary

MeasureTime frame
Mini-mental State Examination;

Countries

China

Contacts

Public ContactBai Feng

Nanjing Drumtower Hospital

baifeng515@126.com+86 13852292309

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026